CSIMarket
 


Genmark Diagnostics Inc   (GNMK)
Other Ticker:  
 
 

Genmark Diagnostics Inc Accounts Receivables Turnover Ratio from the forth quarter 2020 to the forth quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Genmark Diagnostics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the forth quarter 2020 to a ratio of 8.51, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the forth quarter 2020. Average receivable collection period, for the Genmark Diagnostics Inc in Dec 31 2020 quarter, has decreased to 43 days, compared to 47 days, in the Sep 30 2020 quarter.

If we take a look into Healthcare sector 77 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2020 from 983 to 998.

What is Receivable Turnover Ratio?
What is Genmark Diagnostics Inc Selling?


What is Receivable Turnover Ratio?




GNMK Receivables Turnover Ratio (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Receivable Change 24.05 % 55.35 % 164.46 % 180.55 % 45.3 %
Y / Y Revenue Change 84.14 % 103.87 % 118.17 % 79.92 % 40.34 %
Receivable Turnover Ratio (TTM) 8.51 7.77 7.17 7.05 8.16
GNMK's Total Ranking # 998 # 983 # 1500 # 1524 # 1529
Average receivable collection period 43 47 51 52 45
Seq. Receivable Change 28.09 % -9.16 % -30.54 % 53.48 % 60.4 %
Seq. Revenue Change 17.43 % 6.39 % 3.47 % 42.45 % 30.01 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 35
Healthcare Sector # 78
Overall Market # 998

Receivable Turnover Ratio Statistics
High Average Low
1.06 0.59 0.16
(Mar 31 2020)   (March 31, 2015)






Financial Statements
Genmark Diagnostics Inc 's Accounts Receivable $ 21 Millions Visit GNMK's Balance sheet
Genmark Diagnostics Inc 's Sales TTM $ 172 Millions Visit GNMK's Income Statement
Where are GNMK's Sales coming from? Visit GNMK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GNMK's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for GNMK's Competitors
Receivables Turnover Ratio for GNMK's Suppliers
Accounts Receivables Turnover Ratio for GNMK's Customers

You may also want to know
GNMK's Growth Rates GNMK's Roa GNMK's Inventory Turnover Ratio GNMK's Dividend Comparisons
GNMK's Profitability Ratios GNMK's Roi GNMK's Asset Turnover Ratio GNMK's Dividend Growth
GNMK's Valuation Ratios GNMK's Roe GNMK's Financial Strength Ratios GNMK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Receivable at quarter ending Dec 31 2020
Harrow Inc   21.95 $ 48.871  Millions$ 2.226  Millions
Nighthawk Biosciences inc   21.04 $ 2.948  Millions$ 0.140  Millions
Cardax Inc   20.81 $ 0.539  Millions$ 0.026  Millions
Advanced Container Technologies Inc   20.49 $ 2.228  Millions$ 0.109  Millions
Durect Corp  19.63 $ 30.111  Millions$ 1.534  Millions
Therapeutic Solutions International Inc   19.46 $ 0.063  Millions$ 0.003  Millions
Aesthetic Medical International Holdings Group Ltd  18.92 $ 133.884  Millions$ 7.078  Millions
Cv Sciences Inc   18.81 $ 24.429  Millions$ 1.299  Millions
Catalyst Pharmaceuticals Inc   18.65 $ 119.073  Millions$ 6.385  Millions
Ascendis Pharma A  17.97 $ 7.787  Millions$ 0.433  Millions
Delcath Systems Inc   17.51 $ 1.646  Millions$ 0.094  Millions
Semler Scientific Inc   17.50 $ 38.603  Millions$ 2.207  Millions
Neurometrix Inc   16.76 $ 7.378  Millions$ 0.440  Millions
Ethema Health Corporation   16.73 $ 0.339  Millions$ 0.020  Millions
Electrocore Inc   16.69 $ 3.496  Millions$ 0.210  Millions
Merus N v   16.57 $ 29.943  Millions$ 1.807  Millions
Chemed Corporation  16.48 $ 2,079.583  Millions$ 126.219  Millions
Myomo Inc   16.46 $ 7.583  Millions$ 0.461  Millions
Avalon Globocare Corp   16.43 $ 1.378  Millions$ 0.084  Millions
Vbi Vaccines Inc  16.32 $ 1.061  Millions$ 0.065  Millions
Agenus Inc  16.15 $ 88.170  Millions$ 5.461  Millions
China Pharma Holdings Inc   15.83 $ 10.866  Millions$ 0.686  Millions
Cytokinetics Incorporated  15.57 $ 55.828  Millions$ 3.586  Millions
Mannkind Corporation  15.56 $ 65.144  Millions$ 4.188  Millions
Rockwell Medical inc   15.12 $ 62.197  Millions$ 4.113  Millions
Skinvisible Inc   14.69 $ 0.153  Millions$ 0.010  Millions
Dariohealth Corp   14.68 $ 7.576  Millions$ 0.516  Millions
Inmode Ltd   14.64 $ 206.107  Millions$ 14.074  Millions
Corcept Therapeutics Inc  14.51 $ 353.874  Millions$ 24.391  Millions
Dmk Pharmaceuticals Corporation  14.15 $ 16.527  Millions$ 1.168  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com